Raffles Medical (SGX: BSL)

1.470 -

-0.030 (-2.00%)
Range 1.470 - 1.500   (2.04%)
Open 1.500
Previous Close 1.500
Buy Price 1.470
Buy Volume 586
Sell Price 1.480
Sell Volume 156.4
Volume 1,316.9
Value 178,435
Remark -
Measurement Type Value
EPS (SGD) 0.045
Trailing EPS (SGD) 0.056
NAV (SGD) 0.51
Cash In Hand (SGD) 0.155
Dividend 0.018
Dividend Yield (%) 1.209
PE 33.04
Trailing PE 26.639
Price / NAV 2.941
Price / Cash In Hand 9.659
Issued & Paid-up Shares 1,854,007,000
Treasury Shares 22,725,000
Market Cap (M) 2,781.01
Par Value (SGD) n.a.
Beta - 75 Days 0.498
R-Squared - 75 Days(%) 3.62
Beta - 500 Days 0.646
R-Squared - 500 Days(%) 7.26
ISIN Code SG1CH4000003
Under CPF Investment Scheme (CPFIS) Yes
Index Components FTSE ST Mid Cap / FTSE ST All-share / FTSE ST All-Share Health Care Index / FTSE ST Large Mid Cap
Delayed prices. Updated at 03 Feb 2023 17:15.
Data powered by
View All Events

About Raffles Medical

Raffles Medical Group Ltd is an integrated healthcare provider, operating medical facilities in approximately 13 cities in Singapore, China, Japan, Vietnam and Cambodia. The principal activities of the Company are the operation of medical clinics and other general medical services. The Company's segments include Healthcare services, Hospital services and Investment holdings. The Healthcare services segment is engaged in the operations of medical clinics and other general medical services; provision of health insurance, trading in pharmaceutical and nutraceutical products and diagnostic equipment, and provision of management and consultancy services. The Hospital services segment is engaged in the provision of specialized medical services and operation of hospitals, and the business of medical laboratories and imaging centers. Its subsidiaries include Raffles Hospital Pte Ltd, Raffles Diagnostica Pte Ltd, Raffles Research Labs Pte Ltd and Raffles Chinese Medicine Pte Ltd.

Loading Chart...